186 related articles for article (PubMed ID: 33860370)
1. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of consolidation-to-tumor ratio in early lung adenocarcinoma: a retrospective cross-sectional study.
Jing W; Liu M; Li W; Li D; Wu Y; Lv F
Quant Imaging Med Surg; 2024 May; 14(5):3366-3380. PubMed ID: 38720835
[TBL] [Abstract][Full Text] [Related]
4. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
[TBL] [Abstract][Full Text] [Related]
5. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
[TBL] [Abstract][Full Text] [Related]
6. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance.
Sun K; Li M; Shang M; Su X; Zhao J; Wang B; Wu C; Zhang L; Yang S; Sun X
Lung Cancer; 2022 Apr; 166():63-69. PubMed ID: 35196635
[TBL] [Abstract][Full Text] [Related]
8. HRCT features between lepidic-predominant type and other pathological subtypes in early-stage invasive pulmonary adenocarcinoma appearing as a ground-glass nodule.
Zhang P; Li T; Tao X; Jin X; Zhao S
BMC Cancer; 2021 Oct; 21(1):1124. PubMed ID: 34666705
[TBL] [Abstract][Full Text] [Related]
9. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219
[TBL] [Abstract][Full Text] [Related]
10. Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers.
Yin J; Xi J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q
Clin Lung Cancer; 2021 Jul; 22(4):324-331. PubMed ID: 33789831
[TBL] [Abstract][Full Text] [Related]
11. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840
[TBL] [Abstract][Full Text] [Related]
12. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
[TBL] [Abstract][Full Text] [Related]
13. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
[TBL] [Abstract][Full Text] [Related]
14. Which will carry more weight when CTR > 0.5, solid component size, CTR, tumor size or SUVmax?
Zhang S; Lin D; Yu Y; Cao Q; Liu G; Jiang D; Wang H; Fang Y; Shen Y; Yin J; Hou Y; Shi H; Ge D; Wang Q; Tan L
Lung Cancer; 2022 Feb; 164():14-22. PubMed ID: 34974221
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
16. Air bronchogram on chest CT in radiological pure-solid appearance lung cancer: Correlation analysis with genetic pathological features and survival outcomes.
Wang Z; Zhu W; Yang M; Du H; Zhou F; Song N; Wan Z; Zhu J; Li W
Eur J Radiol; 2023 Dec; 169():111194. PubMed ID: 37976762
[TBL] [Abstract][Full Text] [Related]
17. Subsolid Lung Adenocarcinomas: Radiological, Clinical and Pathological Features and Outcomes.
Lai J; Li Q; Fu F; Zhang Y; Li Y; Liu Q; Chen H
Semin Thorac Cardiovasc Surg; 2022; 34(2):702-710. PubMed ID: 34087379
[TBL] [Abstract][Full Text] [Related]
18. Tumor size, but not consolidation-to-tumor ratio, is an independent prognostic factor for part-solid clinical T1 non-small cell lung cancer.
Li Z; Xu W; Gu T; Cao X; Wu W; Chen L
Thorac Cancer; 2023 Feb; 14(6):602-611. PubMed ID: 36578128
[TBL] [Abstract][Full Text] [Related]
19. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
[TBL] [Abstract][Full Text] [Related]
20. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
